PROS1 and COVID-19: Sera of convalescent COVID-19 patients exhibited high reactivity against pools of B cell epitopes corresponding to the N-terminal (peptides 1 to 20), central (peptides 71 to 110), and C-terminal (peptides 171 to 181) portion of the S protein.